These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33311986)

  • 1. Genetic Variability in the microRNA Binding Sites of
    Garcia Mesa K; Bermejo JL; Torres D; Gilbert M; Plass C; Hamann U
    Onco Targets Ther; 2020; 13():12281-12287. PubMed ID: 33311986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between genetic ancestry and common breast cancer susceptibility variants in Colombian women.
    Torres D; Lorenzo Bermejo J; Garcia Mesa K; Gilbert M; Briceño I; Pohl-Zeidler S; González Silos R; Boekstegers F; Plass C; Hamann U
    Int J Cancer; 2019 May; 144(9):2181-2191. PubMed ID: 30485434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.
    Saetrom P; Biesinger J; Li SM; Smith D; Thomas LF; Majzoub K; Rivas GE; Alluin J; Rossi JJ; Krontiris TG; Weitzel J; Daly MB; Benson AB; Kirkwood JM; O'Dwyer PJ; Sutphen R; Stewart JA; Johnson D; Larson GP
    Cancer Res; 2009 Sep; 69(18):7459-65. PubMed ID: 19738052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
    Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
    Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen withdrawal, increased breast cancer risk and the KRAS-variant.
    McVeigh TP; Jung SY; Kerin MJ; Salzman DW; Nallur S; Nemec AA; Dookwah M; Sadofsky J; Paranjape T; Kelly O; Chan E; Miller N; Sweeney KJ; Zelterman D; Sweasy J; Pilarski R; Telesca D; Slack FJ; Weidhaas JB
    Cell Cycle; 2015; 14(13):2091-9. PubMed ID: 25961464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
    Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
    J Genet; 2020; 99():. PubMed ID: 32366738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-nucleotide polymorphism in microRNA-binding site of SULF1 target gene as a protective factor against the susceptibility to breast cancer: a case-control study.
    Zhou Q; Jiang Y; Yin W; Wang Y; Lu J
    Onco Targets Ther; 2016; 9():2749-57. PubMed ID: 27274271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Variants in pre-miR-146a, pre-miR-499, pre-miR-125a, pre-miR-605, and pri-miR-182 Are Associated with Breast Cancer Susceptibility in a South American Population.
    Morales S; De Mayo T; Gulppi FA; Gonzalez-Hormazabal P; Carrasco V; Reyes JM; Gómez F; Waugh E; Jara L
    Genes (Basel); 2018 Aug; 9(9):. PubMed ID: 30135399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility.
    Cao J; Luo C; Yan R; Peng R; Wang K; Wang P; Ye H; Song C
    Med Oncol; 2016 Dec; 33(12):135. PubMed ID: 27807724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population.
    Morales S; Gulppi F; Gonzalez-Hormazabal P; Fernandez-Ramires R; Bravo T; Reyes JM; Gomez F; Waugh E; Jara L
    BMC Genet; 2016 Jul; 17(1):109. PubMed ID: 27421647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-485-5p binding site SNP rs8752 in HPGD gene is associated with breast cancer risk.
    He N; Zheng H; Li P; Zhao Y; Zhang W; Song F; Chen K
    PLoS One; 2014; 9(7):e102093. PubMed ID: 25003827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMPR1B up-regulation via a miRNA binding site variation defines endometriosis susceptibility and CA125 levels.
    Chang CY; Chen Y; Lai MT; Chang HW; Cheng J; Chan C; Chen CM; Lee SC; Lin YJ; Wan L; Tsai PW; Yang SH; Chung C; Sheu JJ; Tsai FJ
    PLoS One; 2013; 8(12):e80630. PubMed ID: 24339876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of correlation between genetic variants in three microRNA genes (hsa-miR-146a, hsa-miR-502 binding site, hsa-miR-27a) and breast cancer risk.
    Parchami Barjui S; Reiisi S; Ebrahimi SO; Shekari B
    Curr Res Transl Med; 2017 Nov; 65(4):141-147. PubMed ID: 29128203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population.
    Wei J; Zheng L; Liu S; Yin J; Wang L; Wang X; Shi Y; Shao A; Tang W; Ding G; Liu C; Chen S; Gu H
    Hum Immunol; 2013 Sep; 74(9):1199-205. PubMed ID: 23792053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas.
    Hoffman J; Fejerman L; Hu D; Huntsman S; Li M; John EM; Torres-Mejia G; Kushi L; Ding YC; Weitzel J; Neuhausen SL; Lott P; ; Echeverry M; Carvajal-Carmona L; Burchard E; Eng C; Long J; Zheng W; Olopade O; Huo D; Haiman C; Ziv E
    Breast Cancer Res; 2019 Jan; 21(1):3. PubMed ID: 30642363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of microRNA 17-92 cluster host gene (MIR17HG) polymorphisms with breast cancer.
    Chacon-Cortes D; Smith RA; Lea RA; Youl PH; Griffiths LR
    Tumour Biol; 2015 Jul; 36(7):5369-76. PubMed ID: 25680407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
    Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
    Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate stem cell antigen single nucleotide polymorphisms influence risk of estrogen receptor negative breast cancer in Korean females.
    Kim SY; Yoo JY; Shin A; Kim Y; Lee ES; Lee YS
    Asian Pac J Cancer Prev; 2012; 13(1):41-8. PubMed ID: 22502712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.
    Nicoloso MS; Sun H; Spizzo R; Kim H; Wickramasinghe P; Shimizu M; Wojcik SE; Ferdin J; Kunej T; Xiao L; Manoukian S; Secreto G; Ravagnani F; Wang X; Radice P; Croce CM; Davuluri RV; Calin GA
    Cancer Res; 2010 Apr; 70(7):2789-98. PubMed ID: 20332227
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.